Matti K. Hakama

Q: What Schools Are Affiliated With Matti K. Hakama

Matti K. Hakama is affiliated with the following schools: Tampere University

Matti K. Hakama's AcademicInfluence.com Rankings

Matti K. Hakama

Medical

#2127

World Rank

#2527

Historical Rank

Public Health

#310

World Rank

#322

Historical Rank

medical Degrees

Download Badge

Medical

Matti K. Hakama's Degrees

PhD Environmental Health University of Helsinki
Masters Environmental Sciences University of Helsinki
Bachelors Environmental Sciences University of Helsinki

Why Is Matti K. Hakama Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Matti K. Hakama's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies (2004) (1529)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up (2014) (1283)
Prostate-cancer mortality at 11 years of follow-up. (2012) (1245)
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials (2015) (934)
TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES (1987) (704)
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks (2007) (691)
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries (2005) (577)
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) (2000) (502)
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries (2004) (440)
Residential radon and lung cancer--detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. (2006) (393)
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries (2005) (351)
Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening (2005) (350)
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer (2000) (302)
Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial (2002) (295)
Serum selenium and subsequent risk of cancer among Finnish men and women. (1990) (278)
Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancer (1994) (269)
Second malignancies following testicular cancer, ovarian cancer and hodgkin's disease: An international collaborative study among cancer registries (1987) (250)
Cervical cancer screening programmes and policies in 18 European countries (2004) (248)
Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. (1988) (248)
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: Recent increase in cervical cancer incidence (1999) (222)
Evaluation of screening programmes for gynaecological cancer. (1985) (218)
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). (2009) (213)
Report on a workshop of the UICC project on evaluation of screening for cancer (1990) (210)
The Effect of Mass Screening on Incidence and Mortality of Squamous and Adenocarcinoma of Cervix Uteri (1995) (208)
High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective study (2004) (191)
Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study (1997) (179)
Prevalence, Incidence, and Estimated Life‐time Risk of Cervical Human Papillomavirus Infections in a Nonselected Finnish Female Population (1990) (175)
Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study (2001) (175)
Organised vs. spontaneous pap‐smear screening for cervical cancer: A case‐control study (1999) (171)
Vitamin E and cancer prevention. (1991) (170)
[Cancer incidence]. (2018) (170)
Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study (1996) (164)
Risk of suicide among cancer patients. (1979) (162)
Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. (2000) (151)
Serum testosterone and sex hormone‐binding globulin concentrations and the risk of prostate carcinoma (1999) (150)
Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. (1990) (143)
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. (1997) (140)
Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme (2010) (139)
Risk indicators for varicose veins in forty- to sixty-year-olds in the tampere varicose vein study (2002) (135)
Cancer screening: evidence and practice in Europe 2008. (2008) (134)
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Design, Epidemiological Methods and Descriptive Results (2007) (132)
Screening for Cancer of the Uterine Cervix (1987) (130)
Association of body mass index with all-cause and cause-specific mortality: findings from a prospective cohort study in Mumbai (Bombay), India. (2008) (126)
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting (2005) (123)
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. (1996) (119)
The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography (2001) (114)
Increasing prevalence of multiple sclerosis in Finland (2001) (112)
Lung cancer following Hodgkin′s disease: A case‐control study (1992) (111)
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. (1988) (109)
Bidirectional relationship between depression and erectile dysfunction. (2007) (109)
Prostate cancer mortality in the Finnish randomized screening trial. (2013) (105)
Circulating enterolactone and prostate cancer risk: A Nordic nested case‐control study (2002) (104)
Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries. (2002) (101)
Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. (2008) (100)
Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland (2012) (99)
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. (1996) (99)
Serum vitamin E, serum selenium and the risk of gastrointestinal cancer (1988) (98)
Mortality and morbidity among the working population of anthophyllite asbestos miners in Finland (1974) (92)
A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen (2004) (92)
A screening programme for cervical cancer that worked. (1988) (91)
Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. (2000) (90)
Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design (2008) (89)
Causes of death among patients with multiple sclerosis (2010) (88)
No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11 (1999) (88)
European School of Oncology Advisory report to the European Commission for the "Europe Against Cancer Programme" European Code Against Cancer. (1995) (87)
Effect of erectile dysfunction on frequency of intercourse: a population based prevalence study in Finland. (2000) (87)
Effect of life-style factors on incidence of erectile dysfunction (2004) (85)
Serum micronutrients and risk of cancers of low incidence in Finland. (1991) (84)
Overexpression of p53 and long-term survival in colon carcinoma. (1994) (84)
Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study. (2002) (82)
European randomized study of prostate cancer screening: first-year results of the Finnish trial (1999) (80)
Regional and Temporal Variation in the Incidence of Multiple Sclerosis in Finland 1979–1993 (2000) (80)
Incidence of cancer among anthophyllite asbestos miners in Finland. (1994) (79)
Estimating the expectation of life in cancer survival studies with incomplete follow-up information. (1977) (79)
Effect of a mass screening program on the risk of cervical cancer. (1976) (79)
Incidence and mortality from breast cancer in the mama program for breast screening in Finland, 1973–1986 (1994) (78)
Oral cancers in Mumbai, India: a fifteen years perspective with respect to incidence trend and cumulative risk. (2004) (77)
Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. (2004) (77)
Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007. (2008) (77)
Ca 15-3 in the follow-up of localised breast cancer: a prospective study. (2002) (74)
Smoking and risk of colorectal cancer. (1998) (73)
Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. (2003) (73)
Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92 (1994) (73)
Prevalence of lower urinary tract symptoms in Finnish men: a population-based study. (1998) (73)
UICC workshop on the evaluation of screening programmes for cancer: Meeting held in Venice, Italy, on November 14‐16, 1983 (1984) (72)
Radon in homes and lung cancer risk: collaborative analysis of individual data from 13 European case-control studies (2005) (72)
Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland (2002) (72)
Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004 (2005) (71)
Association of smoking with lower urinary tract symptoms. (1998) (71)
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening (2006) (71)
Survival of cancer patients in Finland in 1953-1974. (1981) (70)
Effect of Screening for Cancer in the Nordic Countries on Deaths, Costs and Quality of Life up to the Year 2017. (1997) (69)
Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years (2004) (69)
Follow-up Cost of Breast Cancer Patients with Localized Disease After Primary Treatment: a Randomized Trial (2005) (69)
The HPV test has similar sensitivity but more overdiagnosis than the Pap test—A randomised health services study on cervical cancer screening in Finland (2013) (68)
Algorithms based on prostate‐specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false‐postitive PSA results in prostate cancer screening (2004) (68)
Lead-time in prostate cancer screening (Finland) (2002) (68)
Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3. (2008) (67)
Radon and lung cancer in Finland. (1996) (65)
Socio demographic and reproductive risk factors for cervical cancer - a large prospective cohort study from rural India. (2012) (65)
Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer (2007) (65)
Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. (2009) (64)
UICC project on screening for cancer: Report of the workshop on screening for breast cancer (1986) (64)
Breast cancer screening with mammography (1993) (64)
Cancer in Finland 1953-1970: incidence, mortality, prevalence. (1975) (63)
Healthy worker effect in the total Finnish population. (1980) (63)
The sense of coherence, occupation and all-cause mortality in the Helsinki Heart Study (2002) (63)
Lead-time in the European Randomised Study of Screening for Prostate Cancer. (2010) (62)
Aggressiveness of screen-detected breast cancers (1995) (62)
Chapter IV. Reduced breast‐cancer mortality with mammography screening‐an assessment of currently available data (1990) (62)
Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses (2003) (61)
Human Papillomavirus 16, 18, and 33 Infections and Risk of Prostate Cancer: A Nordic Nested Case-Control Study (2005) (59)
The sense of coherence and incidence of cancer--role of follow-up time and age at baseline. (2006) (59)
Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland. (2001) (58)
Association of non-urological diseases with lower urinary tract symptoms. (2001) (57)
Evaluation and monitoring of screening programmes (2001) (57)
Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]. (2006) (57)
Second Round Results of the Finnish Population-Based Prostate Cancer Screening Trial (2004) (57)
Screening for cancer of the uterine cervix. From the IARC Working Group on Cervical Cancer Screening and the UICC Project Group on the Evaluation of Screening Programmes for Cancer. (1986) (56)
Effects of age, comorbidity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS). (2004) (56)
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction. (2001) (56)
Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination. (2002) (56)
Prevalence and severity of erectile dysfunction in 50 to 75-year-old Finnish men. (2003) (55)
Sensitivity in cancer screening (2007) (54)
Comparison of HPV test versus conventional and automation‐assisted Pap screening as potential screening tools for preventing cervical cancer (2004) (54)
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. (1993) (54)
Coverage and Performance of Colorectal Cancer Screening with the Faecal Occult Blood Test in Finland (2011) (53)
Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS). (2008) (52)
Effect of nonsteroidal anti-inflammatory drug use on the incidence of erectile dysfunction. (2006) (52)
Cardiovascular drug use and the incidence of erectile dysfunction (2007) (51)
Risk indicators of breast and cervical cancer on ecologic and individual levels. (1982) (51)
Chernobyl fallout and outcome of pregnancy in Finland. (2001) (51)
Effect of lower urinary tract symptoms on the incidence of erectile dysfunction. (2005) (51)
Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter. (2008) (50)
Varicose veins in a Finnish population aged 40-60. (1993) (50)
Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: A nationwide case‐control study in Finland (1976) (50)
Family history and prostate cancer screening with prostate-specific antigen. (2002) (49)
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. (1997) (49)
Cereal consumption and gastric cancer (1967) (49)
Effect of chronic diseases on incidence of erectile dysfunction. (2003) (49)
Cancer Incidence in Multiple Sclerosis: A 35-Year Follow-Up (2004) (48)
Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population. (1993) (48)
Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. (2004) (48)
Survival of multiple sclerosis in Finland between 1964 and 1993 (2002) (48)
Implementation of screening as a public health policy: issues in design and evaluation (1999) (47)
Incidence of nocturia in 50 to 80-year-old Finnish men. (2006) (46)
Way of life and cancer incidence in Finland. (1980) (46)
Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland (2015) (46)
UICC workshop of the project on evaluation of screening programmes for gastrointestinal cancer (1986) (46)
Three-year results of the Finnish prostate cancer screening trial. (2001) (45)
Regular intercourse protects against erectile dysfunction: Tampere Aging Male Urologic Study. (2008) (44)
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. (2004) (44)
The role of parents, friends and teachers in adolescents' cigarette smoking and tombak dipping in Sudan (2010) (43)
Prospective and randomised public‐health trial on neural network‐assisted screening for cervical cancer in Finland: Results of the first year (2003) (43)
Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme. (2008) (41)
The Finnish trial of prostate cancer screening: where are we now? (2003) (41)
Alternative technologies in cervical cancer screening: a randomised evaluation trial (2006) (40)
Risk of breast cancer and changes in mammographic parenchymal patterns over time. (1998) (39)
The effects of lifestyle factors on the incidence of nocturia. (2008) (39)
Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries) (2000) (38)
Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications. (1975) (38)
COMBINED EFFECT OF ASBESTOS EXPOSURE AND TOBACCO SMOKING ON FINNISH ANTHOPHYLLITE MINERS AND MILLERS (1979) (38)
Randomised health services studies (2012) (38)
Chlamydial Antibodies and Risk of Prostate Cancer (2005) (38)
Defects of the central nervous system in Finland: I. Variations in time and space, sex distribution, and parental age. (1977) (38)
Effectiveness of routine and spontaneous follow-up visits for breast cancer. (1989) (38)
The visibility of cancer on earlier mammograms in a population-based screening programme. (1999) (37)
Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies—a prospective study (1993) (37)
Defects of the central nervous system in Finland. II. Birth order, outcome of previous pregnancies and family history. (1978) (36)
Misclassification in a questionnaire survey of varicose veins. (1995) (36)
Hysterectomy and subsequent risk of cancer. (1997) (35)
Impact of LUTS using bother index in DAN-PSS-1 questionnaire. (2007) (35)
Breast cancer screening as public health policy in Finland. (1991) (35)
Cancer risk among glass factory workers: an excess of lung cancer? (1990) (35)
Joint effects of tobacco use and body mass on all-cause mortality in Mumbai, India: results from a population-based cohort study. (2007) (35)
Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. (2001) (34)
Tumor characteristics in a population-based prostate cancer screening trial with prostate-specific antigen. (2003) (34)
Cancer risk following low doses of ionizing radiation – a retrospective cohort study in 15 countries (2005) (33)
Evaluating Effectiveness of Primary Prevention of Cancer (1991) (33)
Breast self-examination and survival from breast cancer (1996) (32)
Erectile dysfunction influences the subsequent incidence of lower urinary tract symptoms and bother (2007) (32)
Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy. (2004) (31)
Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening (1993) (31)
Association between the bothersomeness of lower urinary tract symptoms and the prevalence of erectile dysfunction. (2005) (31)
Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland. (1996) (30)
The cost‐effectiveness of nationwide breast carcinoma screening in Finland, 1987–1992 (1999) (30)
Incremental cost‐effectiveness of double‐reading mammograms (1999) (29)
Risk factors for contralateral breast cancer in Chennai (Madras), India. (1998) (29)
Risk of cervical cancer after a negative Pap smear (1999) (29)
Selective screening: theory and practice based on high-risk groups of cervical cancer. (1979) (29)
Favorable change in mammographic parenchymal patterns and breast cancer risk factors (1998) (29)
Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up (2016) (28)
Effectiveness of screening for breast cancer in women under 50 years at entry: The Kotka pilot project in Finland (1995) (28)
Association of Dietary Elements and Lower Urinary Tract Symptoms (2000) (27)
Relationship between smoking and erectile dysfunction (2005) (27)
Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial (2007) (27)
Test sensitivity of prostate‐specific antigen in the Finnish randomised prostate cancer screening trial (2004) (27)
Cervical cancer patterns with automation‐assisted and conventional cytological screening: A randomized study (2011) (26)
Independent risk factors of benign and malignant breast lesions. (1981) (26)
A randomized trial of the choice of treatment in prostate cancer: design and baseline characteristics (2001) (26)
PLEURAL PLAQUES AND NEOPLASIA IN FINLAND (1979) (26)
Incidence, mortality or prevalence as indicators of the cancer problem (1975) (25)
Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening (2008) (25)
Episode sensitivity in association with process indicators in the Finnish breast cancer screening program (2006) (25)
Outcome-Based Equity in the Treatment of Colon Cancer Patients in Finland (1989) (25)
EPIDEMIOLOGICAL EVIDENCE FOR TWO COMPONENTS OF CERVICAL CANCER (1981) (24)
Failure of selective screning for breast cancer by combining risk factors (1978) (24)
DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential (1988) (24)
Sensitivity, effect and overdiagnosis in screening for cancers with detectable pre‐invasive phase (2015) (24)
Effect of Family History on the Incidence of Varicose Veins: A Population-Based Follow-Up Study in Finland (2009) (24)
Is a dense mammographic parenchymal pattern a contraindication to hormonal replacement therapy? (2000) (24)
Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer (2010) (23)
Effect of population screening for carcinoma of the uterine cervix in Finland. (1985) (23)
A randomised public‐health trial on automation‐assisted screening for cervical cancer in Finland: Performance with 470,000 invitations (2005) (23)
Potential contribution of screening to cancer mortality reduction. (1993) (23)
Seropositivity to Multiple Sexually Transmitted Infections Is Not Common (2000) (23)
Socioeconomic differences in incidence of cervical cancer in Finland by cell type (2010) (23)
Persons With Varicose Veins Have a High Subsequent Incidence of Arterial Disease: A Population-Based Study in Tampere, Finland (2007) (22)
Randomized Trial with Fruits and Vegetables in Prevention of Cancer (2003) (22)
Bleeding symptoms and subsequent risk of gynecological and other cancers (1998) (22)
Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy. (1995) (22)
RISK OF CERVICAL CANCER AMONG AN ELECTROCOAGULATED POPULATION (1978) (21)
The effects of parity, oral contraceptive use and hormone replacement therapy on the incidence of varicose veins (2006) (21)
Treatment of the terminal stages of breast cancer. (1989) (21)
Validity of process indicators of screening for breast cancer to predict mortality reduction (2005) (21)
Predictions of epidemiology and the evaluation of cancer control measures and the setting of policy priorities. (1991) (20)
Loss-adjusted survival of cervix cancer in Khon Kaen, Northeast Thailand (2004) (20)
Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening (2012) (20)
Survival from contralateral breast cancer (1999) (20)
Incidence of varicose veins in Finland. (2004) (19)
Effect of screening in the Nordic cancer control up to the year 2017. (1997) (19)
Serum ceruloplasmin and the risk of cancer in Finland. (1992) (19)
Randomized evaluation trial on automation-assisted screening for cervical cancer: Results after 777,000 invitations (2007) (19)
The visibility of cancer on previous mammograms in retrospective review. (2001) (19)
Changes in prevalence of urinary symptoms in Finnish men (2004) (19)
Selective screening for cervical cancer. Experience of the Finnish mass screening system. (1977) (19)
Unfavourable change in mammographic patterns and the breast cancer risk factors (1999) (18)
The impact of interscreening interval and age on prostate cancer screening with prostate-specific antigen. (2012) (18)
Smoking causes erectile dysfunction through vascular disease. (2006) (18)
Effect of screening on the risk estimates of socio demographic factors on cervical cancer - a large cohort study from rural India. (2013) (18)
Age‐related incidence of cervical cancer supports two aetiological components: a population‐based register study (2016) (18)
Cancer Incidence Among Finnish Nuclear Reactor Workers (2002) (18)
Cancer risk among rubber workers. (1980) (18)
Breast cancer incidence and mortality in the Nordic capitals, 1970–1998. Trends related to mammography screening programmes (2006) (17)
Role of Chest X-ray in Diagnosis of the First Breast Cancer Relapse: A Randomized Trial (2003) (17)
Lifestyle factors and varicose veins: does cross-sectional design result in underestimate of the risk? (2010) (17)
High-throughput epidemiology: Combining existing data from the Nordic countries in health-related collaborative research (2010) (17)
Decreasing trend in the incidence of stomach cancer in Mumbai, India, during 1988 to 1999. (2004) (16)
Screening for colorectal cancer (1997) (16)
A Screening Programme that Worked: Discussion Paper (1990) (16)
CANCER ILLNESS IN FINLAND WITH A NOTE ON THE EFFECTS OF AGE ADJUSTMENT AND EARLY DIAGNOSIS. (1964) (16)
Effect of radiotherapy on the interpretation of routine follow-up mammography after conservative breast surgery: a randomized study. (1998) (16)
Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland. (2007) (16)
The sense of coherence and risk of injuries: role of alcohol consumption and occupation (2007) (16)
High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma. (1995) (15)
Arterial disease but not hypertension predisposes to varicose veins (2008) (15)
The peculiar age specific incidence curve for cancer of the breast--Clemmesen's hook. (1969) (15)
A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over‐detection (2012) (15)
A 25-year follow-up of a population screened with faecal occult blood test in Finland (2007) (14)
The Finnish prostate cancer screening trial: Analyses on the screening failures (2015) (14)
Sauna, dust and migration as risk factors in lung cancer among smoking and non‐smoking males in Finland (1985) (13)
Effect of family history on the risk of varicose veins is affected by differential misclassification. (2010) (13)
Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region (2010) (13)
Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40–49 in Finland (2011) (13)
Serum p53 accumulation and altered antibody responses to Epstein‐Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin (1996) (13)
Prevalence and bother of postmicturition dribble in Finnish men aged 30–80 years: Tampere Ageing Male Urologic Study (TAMUS) (2012) (13)
[Survival of cancer patients in Finland 1953-74]. (1982) (13)
Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands (2009) (12)
Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study. (2007) (12)
Validity of radiological examinations of patients with breast cancer in different age groups in a population based study. (2001) (12)
Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
Tobacco Use or Body Mass – Do They Predict Tuberculosis Mortality in Mumbai, India? Results from a Population-Based Cohort Study (2012) (12)
Cumulative risk and trends in prostate cancer incidence in Mumbai, India. (2004) (12)
Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer. (2001) (12)
Risk of cervical cancer subsequent to a positive screening cytology: follow‐up study in Finland (2000) (12)
Epidemiologic evidence for multi‐stage theory of carcinogenesis (1971) (12)
Chemoprevention of cancer. (1998) (12)
Empirical evaluation of grouping of lower urinary tract symptoms: principal component analysis of Tampere Ageing Male Urological Study data (2013) (11)
Is Reduced Quality of Life in Men with Lower Urinary Tract Symptoms due to Concomitant Diseases? (2001) (11)
Survival of in situ carcinoma of cervix uteri: A 50‐year follow‐up in Finland (2004) (11)
Reliability of histopathologic diagnosis of malignant lymphoma. (1973) (11)
The variation of process indicators between ten Finnish screening centres in 1991–2000 (2004) (11)
Relation between smallpox vaccination and outcome of pregnancy. (1968) (11)
Tumour Markers and Screening for Gastrointestinal Cancer: A Follow up Study in Finland (1994) (11)
Correspondence re: B-L. Adam et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res., 62: 3609-3614, 2002. (2003) (11)
Lack of serum antibodies to the major HSV‐2 specified DNA‐binding protein before diagnosis of cervical neoplasia (1989) (11)
Chemoprevention in cancer control (1996) (11)
Survival trends for neuroblastoma patients in Finland: negative reflections on screening. (1992) (11)
Effect of type of screening laboratory on population‐based occurrence of cervical lesions in Finland (2002) (10)
Smoking and survival from lung cancer. (1999) (10)
Loss-adjusted hospital and population-based survival of cancer patients. (2011) (10)
Cancer incidence among finnish rubber workers (1982) (10)
Breast cancer incidence: geographical correlations in Finland. (1979) (10)
Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland (1992) (10)
End results of breast cancer patients in Finland 1953-1968. (1974) (10)
Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland (2011) (9)
Linkage of serum sample bank and cancer registry in epidemiological studies. (1990) (9)
Oesophageal cancer incidence in 20-year follow-up in a population-based sample of 12 000 middle-age men with or without Helicobacter pylori infection in Finland (2017) (9)
Re: Prospective study of serum micronutrients and ovarian cancer. (1996) (9)
The incidence and cardiovascular risk indicators of deep venous thrombosis. (1999) (9)
Cervix cancer in Khon Kaen, northeast Thailand, 1985-1999. (2003) (9)
Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy. (2004) (9)
CERVICAL CANCER SCREENING (1987) (9)
Low biological aggressiveness of screen‐detected lung cancers may indicate over‐diagnosis (1996) (9)
Prevalence of hesitancy in 30–80‐year‐old Finnish men: Tampere Ageing Male Urological Study (TAMUS) (2012) (9)
RAUWOLFIA AND BREAST CANCER (1976) (8)
Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]. (2006) (8)
Predicting the effectiveness of the Finnish population-based colorectal cancer screening programme (2017) (8)
Cervical cancer: risk groups for screening. (1986) (8)
Analytical decision model for sample size and effectiveness projections for use in planning a population-based randomized controlled trial of colorectal cancer screening. (2011) (8)
Chemoprevention research in Europe (1997) (7)
Defining expected mortality in occupational studies. (1979) (7)
Population breast-cancer screening (1995) (7)
Effect of a pre-screening survey on attendance in colorectal cancer screening: A double-randomized study in Finland (2014) (7)
The multistage theory of carcinogenesis (1977) (7)
Risk of Endometrial, Ovarian, Vulvar, and Vaginal Cancers After a Positive Cervical Cytology Followed by Negative Histology (1998) (7)
Cancer screening for medical oncologists: definitions and aims. (2002) (7)
Risk of invasive cancer among women visually screened and colposcopy triaged by trained nurses in rural south India (2015) (7)
Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial (2012) (7)
Second Cancers Following Radiation Treatment for Cervical Cancer. An International Collaboration Among Cancer Registries (1985) (7)
Projection of cancer incidence: experiences and some results in Finland. (1980) (7)
The Different Incidence of Gastric Cancer all over the World and Possible Reasons for this Difference (1967) (6)
[Mass screening for cervical cancer in a high risk group]. (1975) (6)
Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trial (2017) (6)
Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial (2006) (6)
Continuity of the doctor/patient relationship during the routine follow-up of a breast cancer patient (1993) (6)
Increase in Years of Life after Eliminating Causes of Death: Significance for Health Priorities (1976) (6)
Survival of Patients With Cervical Cancer in Rural India (2015) (6)
Chlamydia trachomatis infection is a risk factor for cervical cancer (2000) (6)
[Survival of breast cancer patients in Finland]. (1985) (6)
Randomized Screening Trial for Prostate Cancer in Finland (2001) (6)
Cervical cancer in Finland and South Wales: implications of end results data on the natural history. (1980) (5)
Screening for cancer. (1986) (5)
SCREENING FOR CERVICAL CANCER (1987) (5)
Effect of intervention on decision making of treatment for disease progression, prostate‐specific antigen biochemical failure and prostate cancer death (2014) (5)
Ulysses contracts for the doctor and for the patient. (2010) (5)
Use of hospital resources in the Finnish colorectal cancer screening programme: a randomised health services study (2015) (5)
Who wants to join preventive trials? – Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757] (2005) (5)
Biological, physical, mental and social dimensions of breast cancer: information based on routine case notes. (1993) (5)
Spillover improved survival in non-invited patients of the colorectal cancer screening programme (2018) (5)
Age-adjustment of incidence rates in cancer epidemiology. (1970) (5)
Report of the Thirteenth International Symposium of the Foundation for Promotion of Cancer Research: cancer screening-past, present and future. (2000) (5)
The risk of congestive heart failure is increased in persons with varicose veins. (2009) (5)
Oral and dental state in Helsinki preschool children. IV. Caries incidence in the deciduous dentition. (1973) (4)
Inverse Association Between Risk Factors for Benign and Malignant Breast Lesions (1979) (4)
[EVALUATION OF END RESULTS IN CANCER]. (1963) (4)
Blood biochemistry and the risk of cancer Effect of sample pooling (2004) (4)
Effect of characteristics of women on attendance in blind and non-blind randomised trials: analysis of recruitment data from the EPHT Trial (2016) (4)
Association of pulmonary tuberculosis and carcinoma of the lung. (1970) (4)
Family history in colorectal cancer surveillance strategies (2006) (4)
UICC workshop on evaluating interventions to reduce cancer risk. Meeting held at Reykjavik, Iceland, September 21–24, 1988 (1989) (4)
Low biological aggressiveness of screen-detected lung cancers may indicate over-diagnosis. (1996) (4)
The effect of screening on the incidence and mortality of cervical cancer in Finland. (1985) (4)
[Effectiveness of cervical cancer screening in Finland]. (1995) (3)
END RESULTS STUDIES ON CANCER OF THE OVARY. (1964) (3)
Evaluation of effectiveness of quality-assured mammography screening in Germany: sample size considerations and design options (2007) (3)
Patient managed clinical trial. (1997) (3)
Planning and evaluating preventive measures. (1985) (3)
[Participation of women in cervical cancer screening]. (1994) (3)
Screening for cervical cancer. (1987) (3)
Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer (2016) (3)
Cancer in Finland 1954-1963. (1969) (3)
INCIDENCE OF ADVANCED PROSTATE CANCER IN THE FINNISH PROSTATE CANCER SCREENING TRIAL (2008) (3)
Blood biochemistry and the risk of cancer. (2004) (3)
To screen or not to screen for cervical cancer. (1993) (3)
Double-reading of plain radiographs--no benefit with regard to earliness of diagnosis of cancer recurrence: a randomised follow-up study. (2004) (3)
Low Serum Selenium Level and Elevated Risk of Lung Cancer (1989) (3)
Cancer Screening: Theory and Applications (2017) (3)
Trends in stomach cancer incidence for male cohorts in Finland. (1972) (3)
Markov chain Monte Carlo inference applied to a complex model for the longitudinal analysis of breast patterns (2002) (3)
Effect of Screening on Variation in Cervical Cancer Survival by Socioeconomic Determinants--a Study from Rural South India. (2015) (2)
Metabolism of 25‐hydroxyvitamin D3 may explain the u‐shaped risk curve for prostate cancer (2004) (2)
Carcinoembryonic antigen levels in sera drawn 1 to 12 years before diagnosis of cervical malignancy. (1988) (2)
[The organization of breast cancer screening in 1987]. (1989) (2)
Estimation of overdiagnosis by detection to incidence ratio in cancer screening (2019) (2)
Demographic effects of the elimination of selected causes of death in Finland (Finnish) (1974) (2)
[The effectiveness of breast cancer screening in Finland]. (1997) (2)
Resource savings in the single reading of plain radiographs by oncologist only in cancer patient follow-up: A randomized study (2005) (2)
Outcomes of medical and surgical treatment for lower urinary tract symptoms (benign prostatic obstruction) – a population‐based cohort study (2014) (2)
Challenges in evaluation of screening for gastric cancer among men based on nonrandomized design (2017) (2)
Effect of a screening programme on breast carcinoma incidence, mortality and survival. (1980) (1)
Characteristics of prostate cancer in the finnish screening trial with Prostate-Specific Antigen (PSA) (2002) (1)
[Prevalence of cervical adenocarcinoma in Finland]. (1995) (1)
countriesretrospective cohort study in 15 Risk of cancer after low doses of ionising (2005) (1)
CANCER REGISTRATION IN FINLAND. (1964) (1)
[Low-dose ionising radiation and cancer risk]. (1998) (1)
[Incidence, mortality and prevalence as indicators of cancer]. (1974) (1)
Terminal stages of breast cancer: changes in clinical practice. (1991) (1)
Reliability and validity of prostate-specific antigen. (2003) (1)
[Prevalence of erectile dysfunctions and coital frequency]. (2000) (1)
[Should we continue with breast cancer screening?]. (1989) (1)
Current Strategies for Cancer Prevention : Chemoprevention (1996) (1)
[Screening of colorectal cancer in Finland and analysis of its cost-effectiveness]. (2003) (1)
Are questions on both achieving and maintaining an erection needed to define erectile dysfunction? (2005) (1)
Scientific basis of screening in early detection. (1986) (1)
Relative harms and merits of postoperative radiation following conservative surgery for low risk breast cancer (2002) (1)
Implications of screening on the biology of cervical cancer. (1986) (1)
[RESULTS OF THE TREATMENT OF BREAST CANCER IN FINLAND, 1953-56]. (1964) (1)
[FACTORS AFFECTING THE INCREASE OF LUNG CANCER MORTALITY IN FINLAND]. (1964) (0)
Defects ofthecentral nervoussysteminFinland: I. Variations intimeandspace,sexdistribution, andparental age (1977) (0)
596Preliminary results from the third round of the Finnish prostate cancer screening trial (2005) (0)
asbestos miners in Finland . Incidence of cancer among anthophyllite (2005) (0)
Circulating AnW-Helicobacter pylori Immunoglobulin A Antibodies and Low Serum Pepsinogen I Level Are Associated with Increased Risk of Gastric Cancer (2005) (0)
Serum tocopherol and incidence of cancer in Finland (1987) (0)
[Basic epidemiologic methods]. (1974) (0)
[Screening for cancer: for good or for bad?]. (1991) (0)
[Smoking and lung cancer]. (1970) (0)
Finasteride, Alpha-Blockers and Risk of Prostate Cancer - A Population Based Case-Control Study (2006) (0)
OBSERVED AND EXPECTED ' NUMBERS OF LUNG CANCER AND CANCER OF DIGESTIVE ORGANS IN DEATHS AMONG ASBESTOS EMPLOYEES AND CONTROLS , BY AGE Lung cancer Cancer of digestive organs Age Asbestos (0)
[Survival experience of patients with cancer in Finland, 1953-1956]. (1963) (0)
Why chemoprevention? (1996) (0)
Increase in Years of Life after Eliminating Causes of Death: Significance for Health Priorities (1976) (0)
Cancer registry and cancer control (1999) (0)
152 Screening failures in Finland: Improving prostate cancer screening (2012) (0)
Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany (2020) (0)
[CANCER STATISTICS RESEARCH. THE FINNISH CANCER REGISTER AND ITS FUNCTION]. (1963) (0)
Overdiagnosis in breast cancer screening (2017) (0)
Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany (2020) (0)
Patient managed clinical trial (in press). (1996) (0)
[Epidemiological cancer research]. (1967) (0)
[Radiation and subsequent primary cancer among cervical cancer patients in Finland]. (1983) (0)
Selective screeningforcervical cancer Experience oftheFinnish massscreening system (1977) (0)
[Results of cervix neoplasm therapy in Finland 1953-68]. (1975) (0)
Changes in importance of items in the social and personal life of breast cancer patients over time (1999) (0)
[Cervical cancer and mass screening]. (1970) (0)
The projection of chronic diseases using data on risk factors and risk factors intervention: the case of cancer. (1984) (0)
[What is the right treatment for breast cancer?]. (1990) (0)
My 50 years (2013) (0)
[Mammographic screening confirmation of breast cancer biological characteristics--a flow cytometric study]. (1989) (0)
Effect of hormonal treatment on menopausal symptoms: experience from the Estonian Postmenopausal Hormone Therapy Trial (EPHT) [ISRCTN35338757] (2020) (0)
Response to Dr Braillon (2011) (0)
Risk of cancer following hysterectomy (1997) (0)
Blinding decreased recruitment in the Estonian postmenopausal hormone prevention trial (2004) (0)
Serum testosterone, sex hormone binding globulin and prostate cancer risk. A Nordic nested case-control study (2004) (0)
Incidence, mortality or prevalence as indicators of the cancer problem (1975) (0)
[Differences in cervical cancer mass screening results in Greater-Helsinki area]. (2000) (0)
[Incidence of lung cancer among Finnish males in the year 2000]. (1980) (0)
In response (2006) (0)
groups of cervical cancer . practice based on high-risk Selective screening : theory and (0)
Subject Index Vol. 40, 2001 (2001) (0)
FINASTERIDE, α-BLOCKERS AND RISK OF PROSTATE CANCER - A POPULATION BASED CASE-CONTROL STUDY (2006) (0)
[Controlled trials and their design]. (1988) (0)
Selective screening: theory and practice high-risk groups of cervical cancer based on (0)
[Efficacy of organized screening in comparison to spontaneous Pap samples in the prevention of invasive cervical cancer]. (2001) (0)
[SURGERY AND/OR RADIATION IN THE TREATMENT OF CANCER. STUDIES ON END-RESULTS]. (1965) (0)
Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement (HRT) therapy (2004) (0)
Screening for lung cancer. (2002) (0)
[Neuroblastoma screening is not needed in Finland]. (1992) (0)
[Incidence of cervical cancer is clearly increasing in Finland]. (1998) (0)
[Smallpox vaccination and pregnancy. The possibilities and limits of the epidemiologic research]. (1968) (0)
Breast cancer screening with mammography. (1993) (0)
Cancer incidence in Finland with a note on difficulties in comparing epidemiological data. (1966) (0)
Cancer survival estimation: the need to correct bias due to outcome-related follow up loss. (1999) (0)
The role of HBCRs as an alternative to PBCRs: An empirical evaluation in India (2014) (0)
EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER (PCa) SCREENING (ERSPC): FIRST-YEAR RESULTS OF FINNISH TRIAL (1999) (0)
384: Did Epidemiology Delay Progress in Cervical Cancer Prevention? (2005) (0)
European case-control studies 13 collaborative analysis of individual data from Radon in homes and risk of lung cancer: (2005) (0)
[Mass screening and the incidence of cervical cancer in the Scandinavian countries]. (1981) (0)
Prevention of Digestive Cancers — The UICC Project on Evaluation of Primary Prevention (1993) (0)
Public health policy on screening for cancer (2000) (0)
Correction to: Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany (2021) (0)
Correction to: Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany (2021) (0)
More study needed on morning erections and erectile dysfunction. (2009) (0)
COMPONENTS OF CERVICAL CANCER (1981) (0)
[Life expectancy of the population and the influence of most occuring causes of death]. (1974) (0)
Society for Social Medicine and the International Epidemiological Association European Group (2001) (0)
[Cancer therapy--difficulties in treatment]. (1967) (0)
[Epidemiologic cancer research]. (1974) (0)
[Screening for cancer still useful and effective]. (2000) (0)
[Why screen for prostate cancer in Finland?]. (1996) (0)
[Not Available]. (2006) (0)
[Biometric attitudes and methods of clinical trials]. (1973) (0)
[About Psa-screening]. (1996) (0)
[Reserpine and breast cancer]. (1974) (0)
[Promises, disappointments and possibilities of screening tests]. (2000) (0)
Cervical cancerinFinlandand SouthWales: implications ofendresults dataon thenatural history (1980) (0)
Contents Vol. 40, 2001 (2001) (0)
Both high and low level of vitamin D are associated with a higher prostate cancer risk. A prediagnostic study in stored sera (2004) (0)
[Epidemiology of breast cancer in Finland]. (1983) (0)
The effect of breast self-examination on breast cancer survival (1991) (0)
P41 OAB: FROM SYMPTOMS TO MANAGEMENTThursday, 27 March, 15.45-17.15, Blue Hall 1THE EFFECT OF LIFESTYLE FACTORS ON THE INCIDENCE OF NOCTURIA (2008) (0)
[Prognosis of breast cancer diagnosed in Finland 1953-68]. (1975) (0)
[Cervix neoplasms and mass screening]. (1970) (0)
[Not Available]. (2007) (0)
SAS Macro Program for Lead-time Bias and Length Bias Adjustment by Stochastic Modelling (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Matti K. Hakama?

Matti K. Hakama is affiliated with the following schools:

Tampere University